Delta Accumulation, LLC Abb Vie Inc. Put Options Transaction History

Delta Accumulation, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $1.97 Million - $2.3 Million	-12,700 Reduced 66.15%	6,500 $1.11 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $3.07 Million - $3.5 Million	19,200 New	19,200 $3.5 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $490,286 - $610,130	3,700 New	3,700 $498,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.17 Million - $1.49 Million	8,500 New	8,500 $1.3 Million

3,699

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.